Falcon Pharms patents expiration
1. Diclofenac Sodium patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5603929 | FALCON PHARMS | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
Nov, 2014
(9 years ago) | |
| US5653972 | FALCON PHARMS | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
Nov, 2014
(9 years ago) | |
Drugs and Companies using DICLOFENAC SODIUM ingredient
Market Authorisation Date: 04 May, 1998
Treatment: Treating or controlling ocular inflammation which comprises topically administering to affected eye a composition comprising an nsaid, a polymeric quaternary ammonium compound and boric acid
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
DICLOFENAC SODIUM family patents
